Twelve researchers from the University of Sydney have been included in the 2018 Clarivate Analytics Highly Cited Researchers List.
The Clarivate Analytics 2018 Highly Cited Researchers List recognised more than 4,000 leading researchers in 21 fields of the sciences and social sciences from around the world, including 17 Nobel laureates.
Now in its fifth year, the annual list identifies influential researchers having the greatest impact on the research community as measured by the rate at which their work is being cited by their peers around the globe. The Web of Science serves as the basis for regular listings of researchers whose citation records position them in the top 1 percent by citations for their field and year.
The 12 researchers were recognised in categories including agricultural sciences, chemistry, clinical medicine, computer science, economics and business, engineering, microbiology, neuroscience and behaviour, social sciences and cross-field.
The new cross-field category was added this year to recognise researchers with substantial influence in several fields but who do not have enough highly cited papers in any one field to be chosen. Three of the University of Sydney researchers were named in the cross-field category.
The Highly Cited Researcher List is used by the Academic Ranking of World Universities (ARWU) to calculate an institution’s Highly Cited score and contributes to its overall institutional score. In 2018, the University of Sydney climbed 15 places, its best result since the ARWU rankings began in 2003.
For more than 30 years Professor Bauman has been a world leader in the study of chronic disease prevention and the development and assessment of prevention research methods. He was instrumental in identifying the health benefits of moderate physical activity and reduced sitting time. He has published more than 525 papers and two books.
Professor Gale’s work has potential future use in the treatment of diseases that are caused by faulty anion transport such as cystic fibrosis and also in the treatment of cancer. Earlier this year he was awarded the prestigious Izatt-Christensen Award for his seminal contributions to the field. He has published more than 250 papers and been named in highly cited researcher lists since 2012.
Professor Halliday leads a research program of approximately 70 researchers tackling non-Alzheimer's neurodegeneration. She is on editorial boards of 5 international journals, and on the Scientific Advisory Boards for a number of international organizations and research institutes. Professor Halliday has produced more than 400 publications from many successfully completed competitive research grants.
Evolutionary biologist Professor Ho’s work has critically changed the way in which biologists use molecular clocks, especially when studying the timescales of recent events in evolution and human prehistory. Professor Ho is an ARC Future Fellow and has received several ARC Discovery Project grants to support his research. He has produced 193 peer-reviewed journal articles and four book chapters.
Professor Holmes has spent more than 25 years researching how pathogens, such as avian influenza and HIV, emerge and spread. He has produced 533 peer-reviewed papers and two highly-regarded books, which have more than 55,000 citations and a h-index of 124. He is an ARC Australian Laureate Fellow and a Fellow of The Royal Society.
Professor Lenzen is a physicist and renewable energies expert. He has contributed major methodological advances and applications in the areas of embodied energy, greenhouse gas emissions, input-output analysis and life-cycle assessment. Professor Lenzen is Associate Editor of the Journal of Industrial Ecology and Editor-in-Chief of the journal Economic Systems Research.
Professor Long is Co-Director of Melanoma Institute Australia. She leads an extensive clinical trials team and laboratory, with a focus on targeted therapies and immuno-oncology in melanoma. She has published more than 200 peer-reviewed papers since 2011 and is the first woman and the first Australian to be President of the prestigious Society for Melanoma Research.
Executive and Clinical Director of the CADE Clinic at Royal North Shore Hospital, Professor Malhi has a longstanding research interest in mood disorders, in particular bipolar disorder and depression. He has published 500 articles including books and book chapters and has been the Editor of the Australian and New Zealand Journal of Psychiatry since 2010.
Director of the Sydney Institute of Agriculture, Professor McBratney is a world-leading soil scientist. He was awarded the VV Dokuchaev medal by the International Union of Soil Sciences, the highest honour in the soil science discipline. Professor McBratney has published some 470 refereed scientific articles with an h-index of 60 and an i-10 index of 192.
Professor Mitchell has made significant contributions in the fields of public health and ophthalmic epidemiology, advancing the knowledge bank of research into macular disease. He is the Director of the Centre for Vision Research at The Westmead Institute for Medical Research and has co-authored more than 920 papers in peer-reviewed journals and 75 books, chapters or letters.
Professor Simes is an international leader in clinical trials research. The founding Director of the NHMRC Clinical Trials Centre and Director of Sydney Catalyst, has played a leadership role in several major clinical trials in cancer, cardiovascular disease, diabetes and neonatal medicine. These have led to gains in survival and better health outcomes through more effective care.
Professor Tao has made ground-breaking contributions in artificial intelligence, computer vision image processing and machine learning. In 2017 he was awarded an ARC Australian Laureate Fellowship and earlier this year he was named a Fellow of the Australian Academy of Science. He has produced more than 500 publications and won many prizes for his research contributions including a prestigious Eureka Prize.